Glenmark Generics Ltd (GGL), a subsidiary of Glenmark Pharmaceuticals Ltd. (Glenmark), has received ANDA approvals for mometasone furoate ointment USP, 0.1 per cent.
Mometasone furoate cream USP, 0.1 per cent and metformin hydrochloride tablets USP 500 mg, 850 mg and 1000 mg and will soon commence marketing and distribution of these products in the US market.
The details can be read here.
No comments:
Post a Comment